The Filings Report

Northrop Grumman Corp.

NOCNYSECIK 1133421Industrials / Aerospace & Defensefiscal year ends December74 quarters since 2008

Revenue, Q3 FY2026
$11.1B
+6.7% on Q3 FY2025
Net income
$1.1B
+2.2% on Q3 FY2025
Free cash flow
$1.4B
+14.6% on Q3 FY2025
Diluted EPS
$7.89
+2.9% on Q3 FY2025
Revenue, TTM
$43.6B
trailing four quarters
Net margin, TTM
10.4%
net income $4.5B
Free cash flow, TTM
$3.8B
$5.3B less $1.4B capex
Cash and equivalents
$3.7B
long-term debt $14.4B, Sep 30, 2026
Shares, 12-month change
−0.5%
142M shares, Sep 30, 2026
Buybacks, TTM
$524M
0.7% of market value
Dividends, TTM
$1.4B
1.7% of market value
Market value
$79.2B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 20, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Northrop Grumman Corp. reported revenue of $11.1B, +6.7% on Q3 FY2025, and net income of $1.1B (+2.2%). Operating margin was 11.4%. Free cash flow, operating cash flow less capital expenditures, was $1.4B ($1.7B less $306M). Diluted earnings per share were $7.89.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 20, 2026.

Revenue and net incomeRevenueNet income
−$5B$0$5B$10B$15BQ4'22, Revenue: $10.0BQ4'22, Net income: $2.1BQ4'22Q1'23, Revenue: $9.3BQ1'23, Net income: $842MQ1'23Q2'23, Revenue: $9.6BQ2'23, Net income: $812MQ2'23Q3'23, Revenue: $9.8BQ3'23, Net income: $937MQ3'23Q4'23, Revenue: $10.6BQ4'23, Net income: −$535MQ4'23Q1'24, Revenue: $10.1BQ1'24, Net income: $944MQ1'24Q2'24, Revenue: $10.2BQ2'24, Net income: $940MQ2'24Q3'24, Revenue: $10.0BQ3'24, Net income: $1.0BQ3'24Q4'24, Revenue: $10.7BQ4'24, Net income: $1.3BQ4'24Q1'25, Revenue: $9.5BQ1'25, Net income: $481MQ1'25Q2'25, Revenue: $10.4BQ2'25, Net income: $1.2BQ2'25Q3'25, Revenue: $10.4BQ3'25, Net income: $1.1BQ3'25Q4'25, Revenue: $11.7BQ4'25, Net income: $1.4BQ4'25Q1'26, Revenue: $9.9BQ1'26, Net income: $875MQ1'26Q2'26, Revenue: $10.9BQ2'26, Net income: $1.1BQ2'26Q3'26, Revenue: $11.1BQ3'26, Net income: $1.1BQ3'26−$5B$0$5B$10B$15BQ4'22, Revenue: $10.0BQ4'22, Net income: $2.1BQ1'23, Revenue: $9.3BQ1'23, Net income: $842MQ1'23Q2'23, Revenue: $9.6BQ2'23, Net income: $812MQ3'23, Revenue: $9.8BQ3'23, Net income: $937MQ3'23Q4'23, Revenue: $10.6BQ4'23, Net income: −$535MQ1'24, Revenue: $10.1BQ1'24, Net income: $944MQ1'24Q2'24, Revenue: $10.2BQ2'24, Net income: $940MQ3'24, Revenue: $10.0BQ3'24, Net income: $1.0BQ3'24Q4'24, Revenue: $10.7BQ4'24, Net income: $1.3BQ1'25, Revenue: $9.5BQ1'25, Net income: $481MQ1'25Q2'25, Revenue: $10.4BQ2'25, Net income: $1.2BQ3'25, Revenue: $10.4BQ3'25, Net income: $1.1BQ3'25Q4'25, Revenue: $11.7BQ4'25, Net income: $1.4BQ1'26, Revenue: $9.9BQ1'26, Net income: $875MQ1'26Q2'26, Revenue: $10.9BQ2'26, Net income: $1.1BQ3'26, Revenue: $11.1BQ3'26, Net income: $1.1BQ3'26

Net income losses drawn in red.

Free cash flow
−$2B$0$2B$4BQ4'22, Free cash flow: $1.6BQ4'22Q1'23, Free cash flow: −$1.0BQ1'23Q2'23, Free cash flow: $615MQ2'23Q3'23, Free cash flow: $869MQ3'23Q4'23, Free cash flow: $1.6BQ4'23Q1'24, Free cash flow: −$976MQ1'24Q2'24, Free cash flow: $1.1BQ2'24Q3'24, Free cash flow: $730MQ3'24Q4'24, Free cash flow: $1.8BQ4'24Q1'25, Free cash flow: −$1.8BQ1'25Q2'25, Free cash flow: $637MQ2'25Q3'25, Free cash flow: $1.3BQ3'25Q4'25, Free cash flow: $3.2BQ4'25Q1'26, Free cash flow: −$1.8BQ1'26Q2'26, Free cash flow: $978MQ2'26Q3'26, Free cash flow: $1.4BQ3'26−$2B$0$2B$4BQ4'22, Free cash flow: $1.6BQ1'23, Free cash flow: −$1.0BQ1'23Q2'23, Free cash flow: $615MQ3'23, Free cash flow: $869MQ3'23Q4'23, Free cash flow: $1.6BQ1'24, Free cash flow: −$976MQ1'24Q2'24, Free cash flow: $1.1BQ3'24, Free cash flow: $730MQ3'24Q4'24, Free cash flow: $1.8BQ1'25, Free cash flow: −$1.8BQ1'25Q2'25, Free cash flow: $637MQ3'25, Free cash flow: $1.3BQ3'25Q4'25, Free cash flow: $3.2BQ1'26, Free cash flow: −$1.8BQ1'26Q2'26, Free cash flow: $978MQ3'26, Free cash flow: $1.4BQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15B$20BQ4'22, Cash and equivalents: $2.6BQ4'22, Long-term debt: $11.8BQ4'22Q1'23, Cash and equivalents: $2.5BQ1'23, Long-term debt: $13.8BQ1'23Q2'23, Cash and equivalents: $3.4BQ2'23, Long-term debt: $13.8BQ2'23Q3'23, Cash and equivalents: $2.1BQ3'23, Long-term debt: $13.8BQ3'23Q4'23, Cash and equivalents: $3.1BQ4'23, Long-term debt: $13.8BQ4'23Q1'24, Cash and equivalents: $3.1BQ1'24, Long-term debt: $14.7BQ1'24Q2'24, Cash and equivalents: $3.3BQ2'24, Long-term debt: $14.7BQ2'24Q3'24, Cash and equivalents: $3.3BQ3'24, Long-term debt: $14.7BQ3'24Q4'24, Cash and equivalents: $4.4BQ4'24, Long-term debt: $14.7BQ4'24Q1'25, Cash and equivalents: $1.7BQ1'25, Long-term debt: $14.2BQ1'25Q2'25, Cash and equivalents: $1.9BQ2'25, Long-term debt: $15.2BQ2'25Q3'25, Cash and equivalents: $2.0BQ3'25, Long-term debt: $15.2BQ3'25Q4'25, Cash and equivalents: $4.4BQ4'25, Long-term debt: $15.2BQ4'25Q1'26, Cash and equivalents: $2.1BQ1'26, Long-term debt: $14.4BQ1'26Q2'26, Cash and equivalents: $2.3BQ2'26, Long-term debt: $14.4BQ2'26Q3'26, Cash and equivalents: $3.7BQ3'26, Long-term debt: $14.4BQ3'26$0$5B$10B$15B$20BQ4'22, Cash and equivalents: $2.6BQ4'22, Long-term debt: $11.8BQ1'23, Cash and equivalents: $2.5BQ1'23, Long-term debt: $13.8BQ1'23Q2'23, Cash and equivalents: $3.4BQ2'23, Long-term debt: $13.8BQ3'23, Cash and equivalents: $2.1BQ3'23, Long-term debt: $13.8BQ3'23Q4'23, Cash and equivalents: $3.1BQ4'23, Long-term debt: $13.8BQ1'24, Cash and equivalents: $3.1BQ1'24, Long-term debt: $14.7BQ1'24Q2'24, Cash and equivalents: $3.3BQ2'24, Long-term debt: $14.7BQ3'24, Cash and equivalents: $3.3BQ3'24, Long-term debt: $14.7BQ3'24Q4'24, Cash and equivalents: $4.4BQ4'24, Long-term debt: $14.7BQ1'25, Cash and equivalents: $1.7BQ1'25, Long-term debt: $14.2BQ1'25Q2'25, Cash and equivalents: $1.9BQ2'25, Long-term debt: $15.2BQ3'25, Cash and equivalents: $2.0BQ3'25, Long-term debt: $15.2BQ3'25Q4'25, Cash and equivalents: $4.4BQ4'25, Long-term debt: $15.2BQ1'26, Cash and equivalents: $2.1BQ1'26, Long-term debt: $14.4BQ1'26Q2'26, Cash and equivalents: $2.3BQ2'26, Long-term debt: $14.4BQ3'26, Cash and equivalents: $3.7BQ3'26, Long-term debt: $14.4BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 20, 2026.

Northrop Grumman Corp. income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 20, 2026Q2 FY2026ended Jun 30, 2026filed Jul 21, 2026Q1 FY2026ended Mar 31, 2026filed Apr 21, 2026Q4 FY2025ended Dec 31, 2025filed Jan 27, 2026Q3 FY2025ended Sep 30, 2025filed Oct 21, 2025Q2 FY2025ended Jun 30, 2025filed Jul 22, 2025Q1 FY2025ended Mar 31, 2025filed Apr 22, 2025Q4 FY2024ended Dec 31, 2024filed Jan 30, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue11,12210,8769,88111,71210,42310,3519,46810,686+6.7%
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative1,0831,0259711,0259851,0161,007843+9.9%
Operating income1,2691,0969891,2711,2421,4255731,089+2.2%
Other income (expense)206737(21)106383126−81.1%
Pretax income1,2981,1681,0301,7401,3231,4275781,551−1.9%
Income tax1747415531322325397287−22.0%
Net income1,1241,0948751,4271,1001,1744811,264+2.2%
Diluted EPS ($)7.897.686.14—7.678.153.32—+2.9%
Diluted shares (millions)142142143—144144145——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 20, 2026.

Northrop Grumman Corp. balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 20, 2026Q2 FY2026ended Jun 30, 2026filed Jul 21, 2026Q1 FY2026ended Mar 31, 2026filed Apr 21, 2026Q4 FY2025ended Dec 31, 2025filed Jan 27, 2026Q3 FY2025ended Sep 30, 2025filed Oct 21, 2025Q2 FY2025ended Jun 30, 2025filed Jul 22, 2025Q1 FY2025ended Mar 31, 2025filed Apr 22, 2025Q4 FY2024ended Dec 31, 2024filed Jan 30, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents3,7442,3072,0904,4031,9571,8991,6854,353+91.3%
Short-term investments—————————
Total current assets16,97715,59014,77015,28714,10514,02613,26714,274+20.4%
Total assets52,49750,76350,00751,37749,30049,45148,46849,359+6.5%
Total current liabilities13,75313,34512,82113,88212,71813,45913,96914,128+8.1%
Long-term debt14,43314,42814,41115,16215,16215,16014,16714,692−4.8%
Total liabilities33,81432,87932,89234,70333,31233,98033,48434,069+1.5%
Stockholders’ equity18,68317,88417,11516,67415,98815,47114,98415,290+16.9%
Shares outstanding (millions)142142142142143143144145—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 20, 2026.

Northrop Grumman Corp. cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 20, 2026Q2 FY2026ended Jun 30, 2026filed Jul 21, 2026Q1 FY2026ended Mar 31, 2026filed Apr 21, 2026Q4 FY2025ended Dec 31, 2025filed Jan 27, 2026Q3 FY2025ended Sep 30, 2025filed Oct 21, 2025Q2 FY2025ended Jun 30, 2025filed Jul 22, 2025Q1 FY2025ended Mar 31, 2025filed Apr 22, 2025Q4 FY2024ended Dec 31, 2024filed Jan 30, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow1,7451,280(1,656)3,8971,557868(1,565)2,578+12.1%
Capital expenditures306302167662301231256816+1.7%
Free cash flow (CFO − capex)1,439978(1,823)3,2351,256637(1,821)1,762+14.6%
Depreciation and amortization3793673724063793503374140.0%
Share repurchases0068456277411480441−100.0%
Dividends paid351351333329330332302299+6.4%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed January 27, 2026.

Income statement

Northrop Grumman Corp. income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Jan 27, 2026FY2024ended Dec 31, 2024filed Jan 30, 2025FY2023ended Dec 31, 2023filed Jan 25, 2024FY2022ended Dec 31, 2022filed Jan 26, 2023FY2021ended Dec 31, 2021filed Jan 27, 2022FY2020ended Dec 31, 2020filed Jan 28, 2021FY2019ended Dec 31, 2019filed Jan 30, 2020FY2018ended Dec 31, 2018filed Jan 31, 2019FY2017ended Dec 31, 2017filed Jan 29, 2018FY2016ended Dec 31, 2016filed Jan 30, 2017FY2015ended Dec 31, 2015filed Feb 1, 2016FY2014ended Dec 31, 2014filed Feb 2, 2015FY2013ended Dec 31, 2013filed Feb 3, 2014FY2012ended Dec 31, 2012filed Feb 5, 2013FY2011ended Dec 31, 2011filed Feb 8, 2012FY2010ended Dec 31, 2010filed Feb 9, 2011FY2009ended Dec 31, 2009filed Feb 9, 2010FY2008ended Dec 31, 2008filed Jul 23, 2009FY2007ended Dec 31, 2007filed Jul 23, 2009
Revenue41,95441,03339,29036,60235,66736,79933,84130,09526,00424,706—————————
Cost of revenue———————————————————
Gross profit———————————————————
Research and development1,1001,1001,2001,2001,1001,100953764639705712569507520543580588564—
Selling, general and administrative4,0333,9924,0143,8733,5973,4133,2903,0112,7122,6322,5662,4052,2562,4502,3502,4672,5713,1433,062
Operating income4,5114,3702,5373,6015,6514,0653,9693,7803,2183,2773,0763,1963,1233,1303,2762,8272,274(263)2,925
Other income (expense)15416824641992107130136441523(3)472837653817
Pretax income5,0685,0162,3465,8368,9383,7282,5483,7424,2292,6812,7902,9372,8632,9653,0832,3662,070(520)2,606
Income tax8868422909401,9335393005131,360638800868911987997462636859855
Net income4,1824,1742,0564,8967,0053,1892,2483,2292,8692,0431,9902,0691,9521,9782,1182,0531,686(1,262)1,790
Diluted EPS ($)29.0828.3413.5331.4743.5419.0313.2218.4916.3411.3210.399.758.357.817.526.825.21(3.77)5.12
Diluted shares (millions)144147152156161168170175176181192212234253282301323335354

Balance sheet

Northrop Grumman Corp. balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Jan 27, 2026FY2024ended Dec 31, 2024filed Jan 30, 2025FY2023ended Dec 31, 2023filed Jan 25, 2024FY2022ended Dec 31, 2022filed Jan 26, 2023FY2021ended Dec 31, 2021filed Jan 27, 2022FY2020ended Dec 31, 2020filed Jan 28, 2021FY2019ended Dec 31, 2019filed Jan 30, 2020FY2018ended Dec 31, 2018filed Jan 31, 2019FY2017ended Dec 31, 2017filed Jan 29, 2018FY2016ended Dec 31, 2016filed Jan 30, 2017FY2015ended Dec 31, 2015filed Feb 1, 2016FY2014ended Dec 31, 2014filed Feb 2, 2015FY2013ended Dec 31, 2013filed Feb 3, 2014FY2012ended Dec 31, 2012filed Feb 5, 2013FY2011ended Dec 31, 2011filed Feb 8, 2012FY2010ended Dec 31, 2010filed Feb 9, 2011FY2009ended Dec 31, 2009filed Feb 9, 2010FY2008ended Dec 31, 2008filed Jul 23, 2009FY2007ended Dec 31, 2007filed Jul 23, 2009
Cash and equivalents4,4034,3533,1092,5773,5304,9072,2451,57911,2252,5412,3193,8635,1503,8623,0023,7013,2741,504963
Short-term investments——————————————2506858——
Total current assets15,28714,27413,70612,48812,42615,34410,6859,68016,5876,8566,3347,7809,4888,3927,74613,7748,6358,243—
Total assets51,37749,35946,54443,75542,57944,46941,08937,65335,12825,61424,42426,57226,38126,54325,41131,41030,25230,197—
Total current liabilities13,88214,12811,94211,5879,5309,5809,4348,2747,0925,6305,4575,8925,8156,0566,13510,0276,9857,449—
Long-term debt15,16214,69213,78611,80512,77714,26112,77014,40015,2667,0706,5265,9285,9303,9243,9294,808———
Total liabilities34,70334,06931,74928,44329,65333,89032,27029,46627,99620,35518,90219,33715,76117,02915,07517,97417,56518,277—
Stockholders’ equity16,67415,29014,79515,31212,92610,5798,8198,1877,1325,3635,5227,23510,6209,51410,33613,43612,56611,92017,687
Shares outstanding (millions)142145150153156167168170174175181198217237253291303——

Cash flow statement

Northrop Grumman Corp. cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Jan 27, 2026FY2024ended Dec 31, 2024filed Jan 30, 2025FY2023ended Dec 31, 2023filed Jan 25, 2024FY2022ended Dec 31, 2022filed Jan 26, 2023FY2021ended Dec 31, 2021filed Jan 27, 2022FY2020ended Dec 31, 2020filed Jan 28, 2021FY2019ended Dec 31, 2019filed Jan 30, 2020FY2018ended Dec 31, 2018filed Jan 31, 2019FY2017ended Dec 31, 2017filed Jan 29, 2018FY2016ended Dec 31, 2016filed Jan 30, 2017FY2015ended Dec 31, 2015filed Feb 1, 2016FY2014ended Dec 31, 2014filed Feb 2, 2015FY2013ended Dec 31, 2013filed Feb 3, 2014FY2012ended Dec 31, 2012filed Feb 5, 2013FY2011ended Dec 31, 2011filed Feb 8, 2012FY2010ended Dec 31, 2010filed Feb 9, 2011FY2009ended Dec 31, 2009filed Feb 9, 2010FY2008ended Dec 31, 2008filed Jul 23, 2009FY2007ended Dec 31, 2007filed Jul 23, 2009
Operating cash flow4,7574,3883,8752,9013,5674,3054,2973,8272,6132,8132,1622,5932,4832,6402,1152,4532,1333,2112,890
Capital expenditures1,4501,7671,7751,4351,4151,4201,2641,249928920471561364331492585473681681
Free cash flow (CFO − capex)3,3072,6212,1001,4662,1522,8853,0332,5781,6851,8931,6912,0322,1192,3091,6231,8681,6602,5302,209
Depreciation and amortization1,4721,3701,3381,3421,2391,2671,265800475456467462495510544555550——
Share repurchases1,6242,5141,5001,5043,7054907441,2633931,5473,1822,6682,3711,3162,2951,1771,1001,5551,175
Dividends paid1,2931,1861,1161,052983953880821689640603563545535543545539525504

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$52K
10 sales by 1 insider; officers and directors $52K
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$26M
61 sales by 6 insiders; officers and directors $26M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Sep 30, 2026Krishna ArvindDirectoraward75$483.48$36K2,837Oct 1, 2026
Sep 30, 2026Brown Marianne CatherineDirectoraward96$483.48$46K11,706Oct 1, 2026
Aug 3, 2026Welsh Mark A IIIDirectoropen-market sale10b5-18$544.53$4K4,480Aug 4, 2026
Aug 3, 2026Welsh Mark A IIIDirectoropen-market sale10b5-119$545.59$10K4,461Aug 4, 2026
Aug 3, 2026Welsh Mark A IIIDirectoropen-market sale10b5-111$546.42$6K4,450Aug 4, 2026
Aug 3, 2026Welsh Mark A IIIDirectoropen-market sale10b5-131$547.42$17K4,419Aug 4, 2026
Aug 3, 2026Welsh Mark A IIIDirectoropen-market sale10b5-110$548.32$5K4,409Aug 4, 2026
Aug 3, 2026Welsh Mark A IIIDirectoropen-market sale10b5-16$549.50$3K4,403Aug 4, 2026
Aug 3, 2026Welsh Mark A IIIDirectoropen-market sale10b5-12$550.68$1K4,401Aug 4, 2026
Aug 3, 2026Welsh Mark A IIIDirectoropen-market sale10b5-12$552.95$1K4,399Aug 4, 2026
Aug 3, 2026Welsh Mark A IIIDirectoropen-market sale10b5-12$553.90$1K4,397Aug 4, 2026
Aug 3, 2026Welsh Mark A IIIDirectoropen-market sale10b5-14$554.14$2K4,393Aug 4, 2026
Jun 30, 2026Brown Marianne CatherineDirectoraward91$509.31$46K11,558Jul 1, 2026
Jun 30, 2026Krishna ArvindDirectoraward71$509.31$36K2,749Jul 1, 2026
May 20, 2026Winston Mary ADirectoraward349$552.17$193K1,609May 21, 2026
May 20, 2026Welsh Mark A IIIDirectoraward349$552.17$193K4,470May 21, 2026
May 20, 2026Turley James SDirectoraward349$552.17$193K6,738May 21, 2026
May 20, 2026Schoewe Thomas MDirectoraward349$552.17$193K16,737May 21, 2026
May 20, 2026Roughead GaryDirectoraward349$552.17$193K12,210May 21, 2026
May 20, 2026Ross Kimberly A.Directoraward349$552.17$193K1,612May 21, 2026
May 20, 2026Krishna ArvindDirectoraward349$552.17$193K2,666May 21, 2026
May 20, 2026Grady Christopher W.Directoraward349$552.17$193K421May 21, 2026
May 20, 2026Brown Marianne CatherineDirectoraward349$552.17$193K11,415May 21, 2026
May 20, 2026Abney David PDirectoraward349$552.17$193K2,824May 21, 2026
May 4, 2026Welsh Mark A IIIDirectoropen-market sale10b5-11$566.60$5674,215May 5, 2026

Full insider history for Northrop Grumman Corp., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
NORTHROP GRUMMAN CORP /DE/, CIK 1133421 on EDGAR
Extract generated
October 21, 2026
Withheld
2 line-years whose four quarters do not sum to the filed year: operating income FY2009, net income FY2016
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: not filed
Gross profit: not filed
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated October 21, 2026.

JSON file
/data/financials/NOC.json